A randomized controlled trial of folate supplementation when treating malaria in pregnancy with sulfadoxine-pyrimethamine
- PMID: 17053829
- PMCID: PMC1617124
- DOI: 10.1371/journal.pctr.0010028
A randomized controlled trial of folate supplementation when treating malaria in pregnancy with sulfadoxine-pyrimethamine
Abstract
Objectives: Sulfadoxine-pyrimethamine (SP) is an antimalarial drug that acts on the folate metabolism of the malaria parasite. We investigated whether folate (FA) supplementation in a high or a low dose affects the efficacy of SP for the treatment of uncomplicated malaria in pregnant women.
Design: This was a randomized, placebo-controlled, double-blind trial.
Setting: The trial was carried out at three hospitals in western Kenya.
Participants: The participants were 488 pregnant women presenting at their first antenatal visit with uncomplicated malaria parasitaemia (density of >or= 500 parasites/microl), a haemoglobin level higher than 7 g/dl, a gestational age between 17 and 34 weeks, and no history of antimalarial or FA use, or sulfa allergy. A total of 415 women completed the study.
Interventions: All participants received SP and iron supplementation. They were randomized to the following arms: FA 5 mg, FA 0.4 mg, or FA placebo. After 14 days, all participants continued with FA 5 mg daily as per national guidelines. Participants were followed at days 2, 3, 7, 14, 21, and 28 or until treatment failure.
Outcome measures: The outcomes were SP failure rate and change in haemoglobin at day 14.
Results: The proportion of treatment failure at day 14 was 13.9% (19/137) in the placebo group, 14.5% (20/138) in the FA 0.4 mg arm (adjusted hazard ratio [AHR], 1.07; 98.7% confidence interval [CI], 0.48 to 2.37; p = 0.8), and 27.1% (38/140) in the FA 5 mg arm (AHR, 2.19; 98.7% CI, 1.09 to 4.40; p = 0.005). The haemoglobin levels at day 14 were not different relative to placebo (mean difference for FA 5 mg, 0.17 g/dl; 98.7% CI, -0.19 to 0.52; and for FA 0.4 mg, 0.14 g/dl; 98.7% CI, -0.21 to 0.49).
Conclusions: Concomitant use of 5 mg FA supplementation compromises the efficacy of SP for the treatment of uncomplicated malaria in pregnant women. Countries that use SP for treatment or prevention of malaria in pregnancy need to evaluate their antenatal policy on timing or dose of FA supplementation.
Conflict of interest statement
Figures
![Figure 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/1617124/bin/pctr.0010028.g001.gif)
![Figure 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/1617124/bin/pctr.0010028.g002.gif)
![Figure 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/1617124/bin/pctr.0010028.g003.gif)
Similar articles
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
-
Mefloquine for preventing malaria in pregnant women.Cochrane Database Syst Rev. 2018 Mar 21;3(3):CD011444. doi: 10.1002/14651858.CD011444.pub2. Cochrane Database Syst Rev. 2018. Update in: Cochrane Database Syst Rev. 2018 Nov 14;11:CD011444. doi: 10.1002/14651858.CD011444.pub3. PMID: 29561063 Free PMC article. Updated. Review.
-
Mefloquine for preventing malaria in pregnant women.Cochrane Database Syst Rev. 2018 Nov 14;11(11):CD011444. doi: 10.1002/14651858.CD011444.pub3. Cochrane Database Syst Rev. 2018. PMID: 30480761 Free PMC article.
-
Plasma folate level and high-dose folate supplementation predict sulfadoxine-pyrimethamine treatment failure in pregnant women in Western kenya who have uncomplicated malaria.J Infect Dis. 2008 Nov 15;198(10):1550-3. doi: 10.1086/592715. J Infect Dis. 2008. PMID: 18831691 Clinical Trial.
-
Drugs for preventing malaria in pregnant women in endemic areas: any drug regimen versus placebo or no treatment.Cochrane Database Syst Rev. 2014 Oct 10;2014(10):CD000169. doi: 10.1002/14651858.CD000169.pub3. Cochrane Database Syst Rev. 2014. PMID: 25300703 Free PMC article. Review.
Cited by
-
Intermittent preventive treatment with sulfadoxine-pyrimethamine versus weekly chloroquine prophylaxis for malaria in pregnancy in Honiara, Solomon Islands: a randomised trial.Malariaworld J. 2013 Jun 29;4:12. doi: 10.5281/zenodo.10894954. eCollection 2013. Malariaworld J. 2013. PMID: 38828109 Free PMC article.
-
Mechanistic insights into the interaction between the host gut microbiome and malaria.PLoS Pathog. 2023 Oct 12;19(10):e1011665. doi: 10.1371/journal.ppat.1011665. eCollection 2023 Oct. PLoS Pathog. 2023. PMID: 37824458 Free PMC article. Review.
-
Micronutrient Status and Dietary Intake of Iron, Vitamin A, Iodine, Folate and Zinc in Women of Reproductive Age and Pregnant Women in Ethiopia, Kenya, Nigeria and South Africa: A Systematic Review of Data from 2005 to 2015.Nutrients. 2017 Oct 5;9(10):1096. doi: 10.3390/nu9101096. Nutrients. 2017. PMID: 28981457 Free PMC article. Review.
-
Safety and benefits of interventions to increase folate status in malaria-endemic areas.Br J Haematol. 2017 Jun;177(6):905-918. doi: 10.1111/bjh.14618. Epub 2017 Mar 29. Br J Haematol. 2017. PMID: 28369746 Free PMC article. Review.
-
Global Call to Action: maximize the public health impact of intermittent preventive treatment of malaria in pregnancy in sub-Saharan Africa.Malar J. 2015 May 18;14:207. doi: 10.1186/s12936-015-0728-x. Malar J. 2015. PMID: 25986063 Free PMC article.
References
-
- World Health Organization, UNICEF. The Africa malaria report 2003. WHO/CDS/MAL/2003.1093. 2003. Available: http://www.rbm.who.int/amd2003/amr2003/amr_toc.htm. Accessed 22 September 2006.
-
- Steketee RW, Nahlen BL, Parise ME, Menendez C. The burden of malaria in pregnancy in malaria-endemic areas. Am J Trop Med Hyg. 2001;64:28–35. - PubMed
-
- Guyatt HL, Snow RW. The epidemiology and burden of Plasmodium falciparum-related anemia among pregnant women in sub-Saharan Africa. Am J Trop Med Hyg. 2001;64:36–44. - PubMed
-
- World Health Organization. A strategic framework for malaria prevention and control during pregnancy in the African region. WHO Regional Office for Africa, Brazzaville, Republic of Congo. AFR/MAL/04/01. 2004. Available: http://www.who.int/malaria/rbm/Attachment/20041004/malaria_pregnancy_str.... Accessed 22 September 2006.
LinkOut - more resources
Full Text Sources